Bisphosphonate treatment in inaccessible osteoid osteomas: An alternative therapeutic approach.


Journal

Joint bone spine
ISSN: 1778-7254
Titre abrégé: Joint Bone Spine
Pays: France
ID NLM: 100938016

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 14 04 2023
revised: 28 04 2023
accepted: 08 05 2023
medline: 4 12 2023
pubmed: 19 5 2023
entrez: 18 5 2023
Statut: ppublish

Résumé

Osteoid osteoma is a benign osteogenic tumour traditionally treated by surgical excision or percutaneous CT-guided procedures. We describe three cases of osteoid osteomas of which the locations were difficult to access, or for which the procedure was potentially unsafe, involving treatment with zoledronic acid infusions. We report here three male 28-to-31-year-old patients with no medical history who had osteoid osteomas located at the second cervical vertebra, the femoral head, and the third lumbar vertebra respectively. These lesions were responsible for inflammatory pain requiring daily treatment with acetylsalicylic acid. Given the impairment risk, all of the lesions were ineligible for surgical or percutaneous treatment. Patients were successfully treated by 3 to 6 monthly zoledronic acid infusions. All patients experienced complete relief of their symptoms allowing aspirin discontinuation, without any side effects. In the first two cases, CT and MRI control showed nidus mineralization and bone marrow oedema regression, correlating with the pain decrease. After 5years of follow-up, there had been no recurrence of the symptoms. In these patients, monthly 4mg zoledronic acid infusions have been safe and effective in the treatment of inaccessible osteoid osteomas.

Identifiants

pubmed: 37201577
pii: S1297-319X(23)00068-4
doi: 10.1016/j.jbspin.2023.105589
pii:
doi:

Substances chimiques

Diphosphonates 0
Zoledronic Acid 6XC1PAD3KF

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

105589

Informations de copyright

Copyright © 2023 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Guillaume Larid (G)

Rheumatology Department, Sainte-Marguerite Hospital, AP-HM, 13009 Marseille, France; Rheumatology Department, Poitiers University Hospital, 86000 Poitiers, France; LITEC Laboratory, University of Poitiers, 86000 Poitiers, France. Electronic address: guillaume.larid@chu-poitiers.fr.

Simon Valayer (S)

Internal Medicine Department, Cochin Hospital, Paris, France.

Clémentine Jacquier (C)

Internal Medicine and Rheumatology Department, Percy Military Teaching Hospital, 92141 Clamart, France.

Pierre Lafforgue (P)

Rheumatology Department, Sainte-Marguerite Hospital, AP-HM, 13009 Marseille, France; Aix-Marseille University, 13284 Marseille, France.

Jean Denis Laredo (JD)

Paris Cité University, 75013 Paris, France; Orthopaedic and Trauma Surgery, Lariboisière Hospital, AP-HP, 75010 Paris, France.

Thao Pham (T)

Rheumatology Department, Sainte-Marguerite Hospital, AP-HM, 13009 Marseille, France; Aix-Marseille University, 13284 Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH